Wu Yiwen, Liu Yuchun, Zhou Chenhui, Wu Yuefei, Sun Jie, Gao Xiang, Huang Yi
Department of Neurosurgery, Ningbo First Hospital, Ningbo Hospital, Zhejiang University School of Medicine, Ningbo, Zhejiang 315010, China.
Department of Neurology, Ningbo First Hospital, Ningbo Hospital, Zhejiang University School of Medicine, Ningbo, Zhejiang 315010, China.
Oxid Med Cell Longev. 2022 Jul 5;2022:3345637. doi: 10.1155/2022/3345637. eCollection 2022.
Caspases are an evolutionarily conserved family of proteases responsible for mediating and initiating cell death signals. In the past, the dysregulated activation of caspases was reported to play diverse but equally essential roles in neurodegenerative diseases, such as brain injury and neuroinflammatory diseases. A subarachnoid hemorrhage (SAH) is a traumatic event that is either immediately lethal or induces a high risk of stroke and neurological deficits. Currently, the prognosis of SAH after treatment is not ideal. Early brain injury (EBI) is considered one of the main factors contributing to the poor prognosis of SAH. The mechanisms of EBI are complex and associated with oxidative stress, neuroinflammation, blood-brain barrier disruption, and cell death. Based on mounting evidence, caspases are involved in neuronal apoptosis or death, endothelial cell apoptosis, and increased inflammatory cytokine-induced by apoptosis, pyroptosis, and necroptosis in the initial stages after SAH. Caspases can simultaneously mediate multiple death modes and regulate each other. Caspase inhibitors (including XIAP, VX-765, and Z-VAD-FMK) play an essential role in ameliorating EBI after SAH. In this review, we explore the related pathways mediated by caspases and their reciprocal regulation patterns after SAH. Furthermore, we focus on the extensive crosstalk of caspases as a potential area of research on therapeutic strategies for treating EBI after SAH.
半胱天冬酶是一类在进化上保守的蛋白酶家族,负责介导和启动细胞死亡信号。过去有报道称,半胱天冬酶的失调激活在神经退行性疾病(如脑损伤和神经炎症性疾病)中发挥着多样但同样重要的作用。蛛网膜下腔出血(SAH)是一种创伤性事件,要么立即致命,要么会引发中风和神经功能缺损的高风险。目前,SAH治疗后的预后并不理想。早期脑损伤(EBI)被认为是导致SAH预后不良的主要因素之一。EBI的机制复杂,与氧化应激、神经炎症、血脑屏障破坏和细胞死亡有关。基于越来越多的证据,半胱天冬酶在SAH后的初始阶段参与神经元凋亡或死亡、内皮细胞凋亡以及凋亡、焦亡和坏死性凋亡诱导的炎症细胞因子增加。半胱天冬酶可以同时介导多种死亡模式并相互调节。半胱天冬酶抑制剂(包括XIAP、VX - 765和Z - VAD - FMK)在改善SAH后的EBI中起着至关重要的作用。在这篇综述中,我们探讨了SAH后半胱天冬酶介导的相关途径及其相互调节模式。此外,我们关注半胱天冬酶的广泛相互作用,将其作为治疗SAH后EBI治疗策略的一个潜在研究领域。